Barclays raised the firm’s price target on Thermo Fisher (TMO) to $650 from $625 and keeps an Overweight rating on the shares. The company’s “recovery is intact” following the Q4 beat, the analyst tells investors in a research note.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TMO:
- Thermo Fisher Scientific: Resilient Organic Growth and Stabilizing End Markets Support Sustained Buy Rating
- Morning Movers: Meta Platforms and Tesla rise after Q4 results
- Thermo Fisher sees FY26 adjusted EPS $24.22-$24.80, consensus $24.68
- Thermo Fisher reports Q4 adjusted EPS $6.57, consensus $6.45
- These Are the Stocks Reporting Earnings Today – January 29, 2026